|
|
|
Insider
Information: |
Prentiss Christopher B |
Relationship: |
Chief Financial Officer |
City: |
Emeryville |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
93.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Adamas Pharmaceuticals Inc |
ADMS |
Chief Financial Officer |
2021-11-24 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(163,767) |
0 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2021-11-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
163,767 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2021-03-22 |
4 |
S |
$5.48 |
$13,273 |
D/D |
(2,422) |
145,017 |
0 |
% |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
147,439 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2021-02-01 |
4 |
S |
$6.36 |
$24,302 |
D/D |
(3,821) |
72,439 |
0 |
% |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2021-01-20 |
4 |
S |
$4.41 |
$11,598 |
D/D |
(2,630) |
76,260 |
0 |
% |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2020-11-02 |
4 |
S |
$3.21 |
$6,581 |
D/D |
(2,050) |
78,890 |
0 |
% |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2020-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
80,940 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2020-01-21 |
4 |
S |
$5.92 |
$7,512 |
D/D |
(1,269) |
70,940 |
0 |
% |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Financial Officer |
|
2019-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
72,209 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2019-07-22 |
4 |
S |
$6.00 |
$6,492 |
D/D |
(1,082) |
47,209 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2019-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
48,291 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2019-03-20 |
4 |
S |
$8.00 |
$9,480 |
D/D |
(1,185) |
29,541 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2018-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
30,726 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2018-12-20 |
4 |
S |
$7.51 |
$1,712 |
D/D |
(228) |
18,226 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2018-03-21 |
4 |
S |
$25.98 |
$14,731 |
D/D |
(567) |
17,758 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
18,325 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting Officer |
|
2017-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
12,405 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Chief Accounting OfficerOffice |
|
2017-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,905 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|